-
Views
-
Cite
Cite
Matthew Dryden, Prosthetic joint infection: managing infection in a bionic era, Journal of Antimicrobial Chemotherapy, Volume 69, Issue suppl_1, September 2014, Pages i3–i4, https://doi.org/10.1093/jac/dku246
- Share Icon Share
Abstract
There is increasing demand for prosthetic joint surgery and patients are becoming more challenging due to an ageing population often with comorbidities and immunosuppression. While prosthetic joint infection (PJI) rates are generally low, infection can be catastrophic for the patient and hence prevention of infection is critical. Infection, when it does occur, is further complicated by the global rise in antimicrobial resistance. This article introduces a series of papers on the epidemiology of PJI, its diagnosis, use of novel inflammatory markers and molecular techniques, clinical presentation, importance of biofilms, treatment guidelines and, finally, various strategies and novel antibiotic treatment regimens.
- aging
- antibiotics
- inflammatory markers
- epidemiology
- biofilms
- bionics
- comorbidity
- drug resistance, microbial
- surgical procedures, operative
- therapeutic immunosuppression
- natural immunosuppression
- infections
- diagnosis
- prosthetic joint infections
- infection prophylaxis
- treatment guidelines
- joint prosthesis